Applied Therapeutics Inc
APLT0.115USD
-0.000-0.26%
Close 12/24, 16:00（ET）Quotes delayed by 15 min
16.65MMarket Cap
LossP/E TTM
Applied Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
455.00K
-95.45%
EPS(YoY)
-0.76
46.75%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its total revenue reached 455.00K, with a year-on-year change of -95.45%.
What is the Earnings Per Share (EPS) of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.757, with a year-on-year change of 46.75%.
What is the net income of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its net income was -105.62M, with a year-on-year change of 11.81%.
What is the net margin of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its net profit margin was -23214.07%, with a year-on-year change of -1836.98%.
What is the gross margin of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -529.97%, with a year-on-year change of --.
What is the Return on Assets (ROA) of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -149.27%, with a year-on-year change of 41.92%.
What is the operating profit of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its operating profit was -104.30M, with a year-on-year change of -61.62%.
What are the current assets of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its current assets were 83.65M, with a year-on-year change of 53.80%.
What are the total assets of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its total assets of Applied Therapeutics Inc were 86.69M, with a year-on-year change of 58.10%.
What are the total liabilities of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its total liabilities of Applied Therapeutics Inc were 29.68M, with a year-on-year change of -58.76%.
What is the total equity of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its total equity of Applied Therapeutics Inc was 57.01M, with a year-on-year change of 432.47%.
What is the net operating income of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its net operating income of Applied Therapeutics Inc was -105.62M, with a year-on-year change of 11.81%.
What is the net investment of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its net investment of Applied Therapeutics Inc was --, with a year-on-year change of -100.00%.
What is the net financing of Applied Therapeutics Inc?
According to Applied Therapeutics Inc's FY2024 earnings report, its net financing of Applied Therapeutics Inc was 113.81M, with a year-on-year change of 52.67%.
